Spondyloarthritis

The Big Picture: How to Assess Disease Activity in Patients with axSpA & PsA in Clinical Practice

December 2, 2021 • By Mary Beth Nierengarten

Tumor Necrosis Factor Inhibitors May Slow the Progression of Spondyloarthritis

November 16, 2021 • By Lara C. Pullen, PhD

Fiscal Year 2022 ICD-10-CM Codes Now in Effect

October 8, 2021 • By From the College

Early & Long-Term Remission of Spondyloarthritis

July 16, 2021 • By Jason Liebowitz, MD

Cytokine Targets & Treatment Developments for Psoriatic Arthritis & Spondyloarthritis

March 15, 2021 • By Carina Stanton

The Effects of IL-17A Inhibitors on the Microbiota

February 16, 2021 • By Vanessa Caceres

MRI & Axial Spondyloarthritis: Experts Discuss Controversies in the Diagnostic Evaluation of axSpA

January 25, 2021 • By Lara C. Pullen, PhD

PG_Traveler / shutterstock.com

Case Report: Is It Reactive or IBD-Associated Arthritis?

January 19, 2021 • By Hanan Ibrahim, MD, Weixia Guo, MD, & Ayad Alkhatib, MD

FDA Receives Upadacitinib Application for Ankylosing Spondylitis & Approves Tramadol Hydrochloride Oral Solution

September 30, 2020 • By Michele B. Kaufman, PharmD, BCGP

Study Finds Health & Financial Benefits in AxSpA Treat-To-Target Strategy

September 11, 2020 • By Thomas R. Collins

1
2
3
…
15
Next Page »